Skip to content

logo

SEARCH icon
  • Investing News
  • Biotech
  • Oil & Gas
  • Health
  • Mining
  • Cannabis
  • Energy
  • Tech
  • Health
  • MORE
    • Entertainment
    • Real Estate
    • Cannabis
    • Trading Tips
    • Food & Beverage
Search

SEARCH FOR AN ARTICLE

  • Investing News
  • Biotech
  • Oil & Gas
  • Health
  • Mining
  • Cannabis
  • Energy
  • Tech
  • Health
  • MORE
    • Entertainment
    • Real Estate
    • Cannabis
    • Trading Tips
    • Food & Beverage

logo

icon

      HomeNYSE:MRK

      NYSE:MRK

      Merck Stock Downturn: A Cautionary Tale for Investors
      Investing News

      Merck Stock Downturn: A Cautionary Tale for Investors

      March 28, 2025
      Wall Street Predicts 92% Upside for Merck Stock: Should You Buy?
      Investing News

      Wall Street Predicts 92% Upside for Merck Stock: Should You Buy?

      February 11, 2025
      Merck 2025 Sales Forecast Disappoints Investors
      Investing News

      Merck 2025 Sales Forecast Disappoints Investors

      February 4, 2025
      Merck’s KEYFORM-007 Study Fails to Meet Colorectal Cancer Goals
      Investing News

      Merck’s KEYFORM-007 Study Fails to Meet Colorectal Cancer Goals

      September 26, 2024
      Merck’s Keytruda Gains First FDA Approval for Mesothelioma Treatment
      Investing News

      Merck’s Keytruda Gains First FDA Approval for Mesothelioma Treatment

      September 19, 2024
      Merck to Acquire Ophthalmology Biotech Company EyeBio
      Investing News

      Merck to Acquire Ophthalmology Biotech Company EyeBio

      May 30, 2024
      Merck’s Combination Therapy Fails Phase III Lung Cancer Study
      Biotech

      Merck’s Combination Therapy Fails Phase III Lung Cancer Study

      March 22, 2024
      FDA Rejects Merck’s Chronic Cough Drug for Second Time
      Investing News

      FDA Rejects Merck’s Chronic Cough Drug for Second Time

      December 21, 2023
      FDA Expands Merck’s Welireg Label for Advanced Renal Cell Carcinoma
      Investing News

      FDA Expands Merck’s Welireg Label for Advanced Renal Cell Carcinoma

      December 15, 2023
      Merck Faces Setback as Keytruda-Lynparza Combo Fails Lung Cancer Study
      Health

      Merck Faces Setback as Keytruda-Lynparza Combo Fails Lung Cancer Study

      December 8, 2023
      1 2 »

       

      LATEST NEWS

      • Investing News General Mills Stock Performance vs. Food & Beverage Peers
      • Investing News Chevron’s 2026 Capex Plan: A Disciplined Path Forward
      • Investing News Costco Earnings Outlook: Buy Before Results?
      • Investing News Cathie Wood Buys Google Stock at Record Highs
      • Investing News Broadcom AVGO Stock Poised for AI-Driven Growth

      All logos, trade names and/or trademarks, artwork and associated imagery are trademarks and/or copyright material of their respective owners.

      • Advertisers
      • Privacy Policy
      • Terms of Use
      • DMCA Policy
      • Disclaimer
      • Contact Us

      SUBSCRIBE

      To get email updates from Micro Cap Watch.

      I want e-mail alerts, updates, and offers and agree to the MicroCapWatch privacy policy.

      Market Jar Media Inc. © 2025